Cited in | International search | Type: | Patent literature | Publication No.: | WO2016055592
[XI] (ENGMAB AG [CH]) [X] 1,2,16,17,19-26,28,29,31-45 * page 9, lines 9-15; figure 1; examples 4-10 * [I] 3-15,18,27,30; | Type: | Patent literature | Publication No.: | WO2017127499
[XI] (JANSSEN BIOTECH INC [US]) [X] 1,2,16,17,19-26,28,29,31-45 * figures 6,8,13; tables 13-18 * [I] 3-15,18,27,30; | Type: | Patent literature | Publication No.: | US2017233472
[AD] (BARAT BHASWATI [US], et al) [AD] 1-45 * paragraph [0244]; figures 12,23-28 *; | Type: | Patent literature | Publication No.: | WO2019084060
[A] (SILVERBACK THERAPEUTICS INC [US]) [A] 1-45 * sequences 362,367 *; | Type: | Non-patent literature | Publication information: | [XI] - JUNPENG QI ET AL, "Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20180529), vol. 115, no. 24, doi:10.1073/pnas.1719905115, ISSN 0027-8424, pages E5467 - E5476, XP055715663 [X] 1,2,16,17,19-26,28,29,31-45 * figures 1-8 * [I] 3-15,18,27,30 | DOI: | http://dx.doi.org/10.1073/pnas.1719905115 | Type: | Non-patent literature | Publication information: | [A] - SATYEN HARISH GOHIL ET AL, "An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors", ONCOIMMUNOLOGY, (20170517), doi:10.1080/2162402X.2017.1326437, page e1326437, XP055500395 [A] 1-45 * figure 1B * | DOI: | http://dx.doi.org/10.1080/2162402X.2017.1326437 | Cited in | by applicant | Type: | Patent literature | Publication No.: | US2017233472
| Type: | Patent literature | Publication No.: | US9856327
| Type: | Patent literature | Publication No.: | US2018369406
| Type: | Non-patent literature | Publication information: | - AL-LAZIKANI et al., JMB, (19970000), vol. 273, pages 927 - 948 | Type: | Non-patent literature | Publication information: | - MACCALLUM et al., J. Mol. Biol., (19960000), vol. 262, pages 732 - 745 | Type: | Non-patent literature | Publication information: | - LEFRANC et al., Dev Comp Immunol., (20030000), vol. 27, no. 1, pages 55 - 77 | Type: | Non-patent literature | Publication information: | - HONEGGERPLUCKTHUN, J Mol Biol, (20010000), vol. 309, no. 3, pages 657 - 70 | Type: | Non-patent literature | Publication information: | - HONEGGERPLUCKTHUN, JMol Biol, (20010000), vol. 309, no. 3, pages 657 - 70 | Type: | Non-patent literature | Publication information: | - TUNNACLIFFE et al., International Immunology, (19890000), vol. 1, pages 546 - 550 | Type: | Non-patent literature | Publication information: | - WANG et al., Cell, (20180000), vol. 9, no. 1, pages 63 - 73 | Type: | Non-patent literature | Publication information: | - BRINKMANNKONTERMANN, MABS, (20170000), vol. 9, pages 182 - 212 | Type: | Non-patent literature | Publication information: | - ZHANG et al., Am J Pathol., (20120000), vol. 181, no. 6, pages 1903 - 10 | Type: | Non-patent literature | Publication information: | - DANESHMANESH et al., LeukLymphoma, (20130000), vol. 54, no. 4, pages 843 - 50 | Type: | Non-patent literature | Publication information: | - DAVE et al., PLoS One, (20120000), vol. 7, page e52655 | Type: | Non-patent literature | Publication information: | - CHOI et al., Cell Stem Cell, (20180000), vol. 22, pages 951 - 959 | Type: | Patent literature | Publication No.: | WO2013US32572
|